Cancer treatment has become increasingly personalised, with oncologists selecting therapies according to the cancer type, stage, biomarkers, previous treatment and overall health of the patient. Immunotherapy is one such approach that supports the immune system in identifying and attacking cancer cells.
Patients considering immunotherapy for cancer in Mohali can consult Dr. Sandeep Kukkar, Medical Oncologist, at Tricity Cancer Centre Chandigarh for a detailed evaluation. However, immunotherapy is not suitable for every cancer patient. Its eligibility and potential benefits depend on the individual diagnosis and supporting medical evidence.
What Is Cancer Immunotherapy?
Cancer immunotherapy is a type of treatment that helps the body’s immune system recognise, target or control cancer cells. Normally, the immune system identifies and destroys infections and abnormal cells. However, some cancer cells can avoid immune detection or produce signals that prevent immune cells from attacking them.
Immunotherapy may help restore or strengthen this natural immune response. Unlike treatments that directly attack cancer cells, certain immunotherapies help immune cells recognise and respond to cancer more effectively.
The treatment may be used alone or combined with chemotherapy, radiation therapy, targeted therapy or surgery. The appropriate approach depends on the cancer type, treatment objective and individual health factors.
How Does Immunotherapy Work and What Makes It Different?
The immune system contains specialised cells and proteins that protect the body from infections and abnormal cellular changes. Some cancers interfere with this defence system by activating biological “checkpoints” that reduce immune activity.
Certain immunotherapy medicines block these signals, allowing immune cells to recognise and attack cancer cells. This mechanism makes immunotherapy different from conventional chemotherapy.
Chemotherapy primarily works by damaging rapidly dividing cells. In contrast, immunotherapy activates or regulates the patient’s immune response. Therefore, its benefits, side effects and response patterns may differ from chemotherapy.
Some patients may experience a meaningful and long-lasting response, while others may not respond to treatment. An oncologist must consider biomarkers, cancer type, disease stage and available clinical evidence before recommending immunotherapy.
Who Is Eligible for Immunotherapy in Mohali?
Eligibility for immunotherapy for cancer in Mohali cannot be determined from the cancer diagnosis alone. A complete assessment is necessary before beginning treatment.
An oncologist may evaluate:
- The type and stage of cancer
- Tumour location and extent of spread
- Biomarker results, including PD-L1 where relevant
- Genetic or molecular features of the tumour
- Previous treatments and their outcomes
- The patient’s general health and organ function
- Existing autoimmune disorders
- History of organ transplantation
- Current medicines or active infections
- Potential treatment benefits and risks
Tests may include imaging, blood investigations, biopsy review and molecular or biomarker testing. Dr. Sandeep Kukkar evaluates the patient’s medical reports and clinical condition before discussing whether immunotherapy may be considered.
Patients should not assume that immunotherapy is automatically better because it is a newer treatment. The right therapy is the one supported by the patient’s specific diagnosis and clinical findings.
Types of Immunotherapy: Options Available in Mohali
Different forms of immunotherapy work through different mechanisms. Patients seeking immunotherapy for cancer in Mohali may be evaluated at Tricity Cancer Centre Chandigarh to understand which options, if any, are appropriate for their condition.
Immune Checkpoint Inhibitors
Checkpoint inhibitors block signals that some tumours use to suppress immune activity. These medicines may target proteins such as PD-1, PD-L1 or CTLA-4.
Monoclonal Antibodies
Monoclonal antibodies are laboratory-produced proteins designed to identify specific targets on cancer cells. Some mark cancer cells for immune destruction, while others interfere with signals that support cancer growth.
Cancer Vaccines
Therapeutic cancer vaccines are different from preventive vaccines. They are designed to stimulate an immune response against an existing cancer and are used only in selected situations.
Cell-Based Immunotherapy
Cell-based treatments involve collecting, modifying or strengthening immune cells before returning them to the patient’s body. These specialised therapies are currently used for selected cancers and require appropriate facilities.
Cytokine Therapy
Cytokines are proteins that regulate immune responses. Laboratory-produced cytokines may sometimes be used to stimulate immune activity, although their role varies between different cancers.
Patients should ask whether the proposed immunotherapy is approved for their diagnosis and supported by appropriate clinical evidence.
Immunotherapy Versus Chemotherapy: How Do They Compare?
Chemotherapy and immunotherapy have different mechanisms, benefits and possible side effects. One is not universally better than the other.
Chemotherapy directly affects rapidly dividing cells. It is used for many cancer types and may work relatively quickly. However, it can also affect healthy rapidly dividing cells, potentially causing nausea, hair loss, reduced blood counts and other side effects.
Immunotherapy works by activating or regulating the immune response. Its side effects may occur when activated immune cells mistakenly affect healthy organs. These immune-related reactions can involve the skin, lungs, liver, intestines, thyroid glands, kidneys or other organs.
In selected cases, immunotherapy and chemotherapy may be used together. Treatment selection depends on established clinical guidelines, tumour characteristics and the patient’s overall condition.
Common Indications: Which Cancers May Respond to Immunotherapy?
Immunotherapy may be used for selected patients with cancers such as:
- Lung cancer
- Melanoma
- Kidney cancer
- Bladder cancer
- Head and neck cancer
- Certain types of breast cancer
- Colorectal cancer with specific biomarkers
- Liver cancer
- Some blood cancers
- Other advanced cancers with eligible biomarkers
Patients exploring immunotherapy for lung cancer in Mohali may require detailed staging and biomarker testing. Lung cancer includes different subtypes, and immunotherapy eligibility can vary accordingly.
Similarly, immunotherapy for breast cancer in Mohali may be considered for selected cases, including certain triple-negative breast cancers. The recommendation depends on the cancer stage, biomarker status and previous treatment history.
Benefits and Possible Side Effects
Potential benefits of cancer immunotherapy may include a durable response in selected patients, a treatment mechanism different from chemotherapy and the possibility of combining it with other therapies.
At Tricity Cancer Centre Chandigarh, patients can discuss the expected benefits, limitations and monitoring requirements associated with their proposed treatment plan.
Possible side effects may include:
- Fatigue or weakness
- Fever
- Skin rash or itching
- Diarrhoea
- Joint discomfort
- Reduced appetite
- Thyroid-related changes
Less commonly, immunotherapy may cause inflammation of the lungs, liver, kidneys, intestines or other organs. Some immune-related reactions can become serious without timely medical care.
Patients should immediately report breathing difficulty, persistent diarrhoea, severe weakness, yellowing of the skin, confusion or other unexpected symptoms. Early detection and management of side effects are important.
How to Choose the Right Immunotherapy Hospital and Oncologist in Mohali
When selecting a hospital or oncologist for immunotherapy in Mohali, patients should consider whether the centre provides comprehensive evaluation, biomarker testing guidance, treatment monitoring and support for managing possible complications.
A qualified immunotherapy doctor in Mohali should clearly explain:
- Why immunotherapy is being considered
- Whether biomarker testing is required
- Alternative treatment options
- Expected benefits and limitations
- Treatment schedule and possible duration
- Potential side effects and warning signs
- Follow-up and monitoring requirements
- Approximate treatment-related expenses
At Tricity Cancer Centre Chandigarh, Dr. Sandeep Kukkar reviews the diagnosis, pathology reports, imaging findings, tumour characteristics and previous treatment history before recommending an appropriate treatment plan. Patients may also consider obtaining a second opinion if they need additional clarity before starting treatment.
Frequently Asked Questions
1. Is immunotherapy suitable for every cancer patient?
No. Immunotherapy is suitable only for selected patients. Eligibility depends on the cancer type, stage, biomarkers, overall health and previous treatment history. A medical oncologist must review the complete clinical information.
2. How long does immunotherapy treatment continue?
The duration varies according to the medicine, treatment protocol, cancer response and side effects. Some patients receive treatment for a fixed period, while others may continue until the cancer progresses or unacceptable side effects occur.
3. Can immunotherapy completely cure cancer?
Immunotherapy may produce meaningful and sometimes long-lasting responses in selected patients, but it cannot guarantee a cure. Outcomes vary according to cancer type, stage, biomarkers and individual response.
Conclusion
Immunotherapy has created valuable treatment possibilities for selected cancer patients. Nevertheless, careful patient selection, biomarker testing and regular monitoring remain essential. Patients considering immunotherapy for cancer in Mohali can consult Dr. Sandeep Kukkar at Tricity Cancer Centre Chandigarh to understand their eligibility, available options, expected benefits and potential risks. A personalised oncology assessment provides the safest basis for deciding whether immunotherapy should form part of an individual cancer treatment plan.
